MAPS donated $11,000 to McLean Hospital, Harvard Medical School, for Dr. Halpern’s work on the protocol design and approval process for a study of MDMA-assisted psychotherapy in subjects with anxiety as a result of end-stage cancer, with outcome measures to evaluate anxiety, pain and quality of life. MAPS has previously donated $15,000 to McLean for this study on June 2003. We plan to submit the protocol to the McLean IRB before the end of Summer 2004.
Ecstasy Agonistes A retracted study on a controversial substance raises questions about the reliability of government-sponsored research on drugs, By Thomas Bartlett, Chronicle of Higher Education
The Chronicle of Higher Education’s February 25, 2004 colloquy live email chat with Rick Doblin is available in the Chronicle archive.